DAVID BALLINGHAM: Open Payments
NPI 1821216722 · HARRISVILLE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,946 in 64 payments from 11 companies in 2025. Trend: 2023 $552 · 2024 $820 · 2025 $11,946
Speaker / faculty: $10,250Food & beverage: $1,129Travel & lodging: $456Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $10,945 |
| Teva Pharmaceuticals USA, Inc. | 12 | $341 |
| Tris Pharma Inc | 2 | $193 |
| Indivior Inc. | 6 | $158 |
| Janssen Pharmaceuticals, Inc | 4 | $91 |
| Collegium Pharmaceutical, Inc. | 4 | $62 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Braeburn Inc. | 2 | $38 |
| Alkermes, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: VRAYLAR, Dyanavel XR, UZEDY, SUBLOCADE, SPRAVATO, Jornay PM, Auvelity, AUSTEDO XR.
Industry payments across UT — which companies pay providers there.
